NCT01075594已完成不适用
Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,500
- 试验地点
- 1
- 主要终点
- The number and percentage of patients achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines
研究概览
简要总结
The purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks
- •Signed Informed Consent
排除标准
- •Informed Consent not provided
结局指标
主要结局
The number and percentage of patients achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines
时间窗: 6 months - one visit only, no follow-up visits
次要结局
- The number and percentage of subjects achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines for several subject subsets(6 months - one visit only, no follow-up visits)
- The number and percentage of subjects achieving LDL-C goals according to the NCEP ATP III / 2004 updated 2004 NCEP ATP III guidelines, overall and for several subject subsets(6 months - one visit only, no follow-up visits)
- The number and percentage of subjects achieving the non HDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III/national guidelines [<130mg/dL (3,37mmol/L)], in the following sub-population: patients with fasting triglycerides >200 mg/dL(6 months - one visit only, no follow-up visits)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Centralized Pan-Russian Survey on the Undertreatment of HypercholesterolemiaDyslipidaemiaNCT01221584AstraZeneca1,000
已完成
不适用
Pan-European Survey on the Under Treatment of HypercholesterolemiaHypercholesterolemiaNCT00542867AstraZeneca6,500
已完成
不适用
Centralized Pan-Middle East Survey on the Undertreatment of HypercholesterolemiaHypercholesterolemiaNCT01025388AstraZeneca4,053
已完成
不适用
Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf StatesHypercholesterolemiaNCT01031277AstraZeneca1,000
已完成
不适用
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)DyslipidaemiaNCT02230241AstraZeneca2,700